Single Assets

TowerBrook has ‘spent considerable money, time and resources’ transforming the professional services business across its four-plus year hold, managing director Walter Weil tells Secondaries Investor.

This is at least the second time the mid-market healthcare-focused firm has run a CV to extend its hold of a top-performing asset.

A higher percentage of LPs choosing to roll into CVs would be a ‘healthy’ sign for the market, Lexington Partners’ Christophe Browne said at NEXUS 2026.

From CVs on CVs to greater specialisation, secondaries professionals who have previously featured on our rising stars list share their insights on the market’s evolution.

The investment bank and placement agent will together focus on co-control deals where GPs are seeking to sell part of a stake via M&A and move the remainder into a CV.

GP-led deal volume hit an all-time high in 2025, but record growth doesn’t necessarily equate to LP satisfaction with continuation vehicle processes.

A&M Capital’s secondaries strategy has a focus on mid-market and smaller deals, which is believes offers a more attractive risk-return profile than the larger end, managing partner Jeremy Weisberg said at NEXUS 2026.

The GP-led market is going from strength to strength, but there are still challenges to address.

With evergreen fund investment in GP-led deals on the rise, how compatible are these transactions with vehicles that offer investors a degree of periodic liquidity and, in most cases, diversified exposures?

Not every company marketed as a trophy asset is indeed a crown jewel, leading to specialised work on behalf of buyers to sort through opportunities, attendees heard at PEI’s NEXUS conference last week.